Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Core+ Starting at $20/month
The answer, based on recent randomized controlled trial data, is that the skeletal cost of GLP-1 therapy deserves serious attention
Patient Selection: With most cardiovascular patients having BMI 27 kg/m, this represents a large eligible population who may derive cardiovascular benefit from semaglutide, independent of achieving substantial weight reduction
Supplementary information Rights and permissions Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material
Who are Ideal Candidates for GLP-1 Medications
US$ 28.18
US$ 22.12
US$ 28.98
